MOG and ocular melanoma: Prophylactic OM-MOG prevented the development of inflammatory demyelinating spinal cord lesions, while therapeutic OM-MOG reversed both clinical and histopathological signs of ongoing EAE in DR2b.Ab° mice, reducing spinal cord immune infiltrates, microglia responses, demyelination and axonal damage.